Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
Clinical trial NCT03448718 · COMPLETED
Trial details
- NCT number
- NCT03448718
- Sponsor
- Matthew Galsky
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2021-07-14
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.